These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36062189)

  • 1. Circ_000829 Plays an Anticancer Role in Renal Cell Carcinoma by Suppressing SRSF1-Mediated Alternative Splicing of SLC39A14.
    Feng JF; Yang WY; Wang YD; Xie G; Xu B; Dai CM; Zhang B; Li XH; Wang J; Yang YW
    Oxid Med Cell Longev; 2022; 2022():8645830. PubMed ID: 36062189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA circ_001842 plays an oncogenic role in renal cell carcinoma by disrupting microRNA-502-5p-mediated inhibition of SLC39A14.
    Zeng J; Feng Q; Wang Y; Xie G; Li Y; Yang Y; Feng J
    J Cell Mol Med; 2020 Sep; 24(17):9712-9725. PubMed ID: 32729666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative splicing of SLC39A14 in colorectal cancer is regulated by the Wnt pathway.
    Thorsen K; Mansilla F; Schepeler T; Øster B; Rasmussen MH; Dyrskjøt L; Karni R; Akerman M; Krainer AR; Laurberg S; Andersen CL; Ørntoft TF
    Mol Cell Proteomics; 2011 Jan; 10(1):M110.002998. PubMed ID: 20938052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNA circ-EGLN3 promotes renal cell carcinoma proliferation and aggressiveness via miR-1299-mediated IRF7 activation.
    Lin L; Cai J
    J Cell Biochem; 2020 Nov; 121(11):4377-4385. PubMed ID: 31904147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-Regulation of Circular RNA_000926 Attenuates Renal Cell Carcinoma Progression through miRNA-411-Dependent CDH2 Inhibition.
    Zhang D; Yang XJ; Luo QD; Fu DL; Li ZL; Zhang P; Chong T
    Am J Pathol; 2019 Dec; 189(12):2469-2486. PubMed ID: 31476285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circ_0037866 Contributes to the Tumorigenesis of Renal Cell Carcinoma by Sequestering miR-384 to Elevate Chromobox 5 Expression.
    Shi X; Song S; Gao Y; Cui Z; Wang W; Liu M
    Kidney Blood Press Res; 2022; 47(5):329-340. PubMed ID: 35249038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CircRNA SCARB1 Promotes Renal Cell Carcinoma Progression Via Mir- 510-5p/SDC3 Axis.
    Sun J; Pan S; Cui H; Li H
    Curr Cancer Drug Targets; 2020; 20(6):461-470. PubMed ID: 32271695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of SRSF1 facilitates osteosarcoma progression and unveils its potential mechanisms.
    Li S; Huang X; Zheng S; Zhang W; Liu F; Cao Q
    BMC Cancer; 2024 May; 24(1):580. PubMed ID: 38735973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SRSF3 suppresses RCC tumorigenesis and progression via regulating SP4 alternative splicing.
    Zhang L; Zhang H; Tang Y; Dai C; Zheng J
    Biochim Biophys Acta Mol Cell Res; 2024 Dec; 1871(8):119841. PubMed ID: 39222664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing circular RNA circ_0054537 and upregulating microRNA-640 suppress malignant progression of renal cell carcinoma via regulating neuronal pentraxin-2 (NPTX2).
    Pei L; Lv X; Jia G; Tan X; Li M; Zhang A
    Bioengineered; 2021 Dec; 12(1):8279-8295. PubMed ID: 34565284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CircSMARCA5 Inhibits Migration of Glioblastoma Multiforme Cells by Regulating a Molecular Axis Involving Splicing Factors SRSF1/SRSF3/PTB.
    Barbagallo D; Caponnetto A; Cirnigliaro M; Brex D; Barbagallo C; D'Angeli F; Morrone A; Caltabiano R; Barbagallo GM; Ragusa M; Di Pietro C; Hansen TB; Purrello M
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29415469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circ_0039569 Competes with MARCKS for miR-133b Binding Sites to Promote the Progression of Renal Cell Carcinoma.
    Zhao P; Zhang J
    Nephron; 2022; 146(4):404-417. PubMed ID: 35086110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of hsa_circ_0001445 reverses oxLDL‑induced inhibition of HUVEC proliferation via SRSF1.
    Liang G; Chen S; Xin S; Dong L
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33982782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor promoting effects of circRNA_001287 on renal cell carcinoma through miR-144-targeted CEP55.
    Feng J; Guo Y; Li Y; Zeng J; Wang Y; Yang Y; Xie G; Feng Q
    J Exp Clin Cancer Res; 2020 Dec; 39(1):269. PubMed ID: 33256799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CircPLCE1 facilitates the malignant progression of colorectal cancer by repressing the SRSF2-dependent PLCE1 pre-RNA splicing.
    Chen Z; Chen H; Yang L; Li X; Wang Z
    J Cell Mol Med; 2021 Aug; 25(15):7244-7256. PubMed ID: 34173324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal circular RNA_400068 promotes the development of renal cell carcinoma via the miR‑210‑5p/SOCS1 axis.
    Xiao H; Shi J
    Mol Med Rep; 2020 Dec; 22(6):4810-4820. PubMed ID: 33173957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SRSF1 modulates PTPMT1 alternative splicing to regulate lung cancer cell radioresistance.
    Sheng J; Zhao Q; Zhao J; Zhang W; Sun Y; Qin P; Lv Y; Bai L; Yang Q; Chen L; Qi Y; Zhang G; Zhang L; Gu C; Deng X; Liu H; Meng S; Gu H; Liu Q; Coulson JM; Li X; Sun B; Wang Y
    EBioMedicine; 2018 Dec; 38():113-126. PubMed ID: 30429088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA hsa_circ_0054537 sponges miR-130a-3p to promote the progression of renal cell carcinoma through regulating cMet pathway.
    Li R; Luo S; Zhang D
    Gene; 2020 Sep; 754():144811. PubMed ID: 32464246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splicing factor SRSF1 promotes gliomagenesis via oncogenic splice-switching of MYO1B.
    Zhou X; Wang R; Li X; Yu L; Hua D; Sun C; Shi C; Luo W; Rao C; Jiang Z; Feng Y; Wang Q; Yu S
    J Clin Invest; 2019 Feb; 129(2):676-693. PubMed ID: 30481162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel circRNA, circNUP98, a potential biomarker, acted as an oncogene via the miR-567/ PRDX3 axis in renal cell carcinoma.
    Yu R; Yao J; Ren Y
    J Cell Mol Med; 2020 Sep; 24(17):10177-10188. PubMed ID: 32729669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.